• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 1, 2025
Distillery Therapeutics

Inhibiting HIF2A for idiopathic pulmonary fibrosis

Read More
BioCentury | Nov 6, 2024
Distillery Therapeutics

Inhibition of HEXB for antitumor immunity in glioblastoma

Read More
BioCentury | Mar 26, 2024
Distillery Therapeutics

HFE2 for blood-brain barrier integrity in MS

Read More
BioCentury | Aug 17, 2023
Discovery & Translation

Improved transgene insertion; plus Synlogic’s autoimmune probiotic and more

BioCentury’s roundup of translational innovations
Read More
BioCentury | Dec 2, 2022
Discovery & Translation

DNA insertion without breaks; plus diffusion-based approaches to protein design and more

BioCentury’s roundup of translational news
Read More
BioCentury | Jun 7, 2022
Distillery Therapeutics

Targeting USP25 for pancreatic cancer

Read More
BioCentury | Apr 1, 2022
Discovery & Translation

An in vivo CAR T manufacturing implant; plus Seer, Kither and more

BioCentury’s roundup of translational news
Read More
BioCentury | Oct 1, 2021
Distillery Therapeutics

HIF-PH inhibitors for manganese toxicity

Read More
BioCentury | May 28, 2020
Distillery Therapeutics

Reducing kidney damage in lupus by targeting HIF1A

Read More
BioCentury | Nov 19, 2019

Combining Arava with HIF1A inhibition to treat RA

Read More
Items per page:
1 - 10 of 65
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa